Torcap Tablets 160mg

Torcap Tablets 160mg, manufactured by AstraZeneca, contains Capivasertib (YJ code: 4291082F1028, standard: 160mg 1 tablet). This medication is a potent, selective inhibitor of all three isoforms of the serine/threonine protein kinase AKT (AKT1, AKT2, and AKT3). It works by blocking AKT activity to help stop the growth and spread of cancer cells, particularly in cancers with PIK3CA, AKT1, or PTEN gene mutations.